Literature DB >> 21723624

Coexistence of osteoporosis (OP) and coronary artery disease (CAD) in the elderly: it is not just a by chance event.

Yusuf Yesil1, Zekeriya Ulger, Meltem Halil, Burçin Halaçli, Burcu Balam Yavuz, Nesibe Karahan Yeşil, Mehmet Emin Kuyumcu, Mustafa Cankurtaran, Servet Ariogul.   

Abstract

Cardiovascular disease (CVD) and OP are common age-related conditions. In both cross-sectional and longitudinal epidemiologic studies, low bone mass has been related to increased frequency of CVD. But available data in geriatric population is limited. In this study we aimed to seek the possible relationship between CAD and low bone mineral density (BMD) in a large number of geriatric patients. A total of 2235 patients aged 65 years or more were included in this cross-sectional study. All patients underwent a complete geriatric assessment and evaluated for CAD and cardiovascular risk factors. BMD was measured by dual-energy X-ray absorptiometry at the lumbar spine (L1-L4) and femoral neck. BMD results were classified into three groups; normal (T-score: ≥-1.0×S.D.), osteopenia (T-score between -1.0 and -2.5×S.D.), and OP (T-score: ≤-2.5×S.D.). CAD was present in 397 (29.7%) of 1335 patients with OP, in 199 (27.4%) of 726 patients with osteopenia and in 34 (19.5%) of 174 patients with normal BMD. Multivariate regression analysis revealed that presence of OP or osteopenia increased the prevalence of CAD as an independent correlate (OR=1.643; 95% CI=1.068-2.528, p=0.030). This study highlights the need for careful evaluation of elderly patients with low BMD for possible CAD.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21723624     DOI: 10.1016/j.archger.2011.06.007

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  8 in total

1.  Hypercholesterolemia promotes an osteoporotic phenotype.

Authors:  Kristine Pelton; Jaclynn Krieder; Danese Joiner; Michael R Freeman; Steven A Goldstein; Keith R Solomon
Journal:  Am J Pathol       Date:  2012-07-04       Impact factor: 4.307

2.  Regulation of calcific vascular and valvular disease by nuclear receptors.

Authors:  Tamer Sallam; Yin Tintut; Linda L Demer
Journal:  Curr Opin Lipidol       Date:  2019-10       Impact factor: 4.776

3.  Meta-analysis of hypertension and osteoporotic fracture risk in women and men.

Authors:  C Li; Y Zeng; L Tao; S Liu; Z Ni; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2017-04-26       Impact factor: 4.507

4.  A cross-sectional study to evaluate the associations between hypertension and osteoporosis in Chinese postmenopausal women.

Authors:  Jin Zhang; Keqin Zhang; Haiming Shi; Zihui Tang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics.

Authors:  Jonas Bovijn; Kristi Krebs; Chia-Yen Chen; Ruth Boxall; Jenny C Censin; Teresa Ferreira; Sara L Pulit; Craig A Glastonbury; Samantha Laber; Iona Y Millwood; Kuang Lin; Liming Li; Zhengming Chen; Lili Milani; George Davey Smith; Robin G Walters; Reedik Mägi; Benjamin M Neale; Cecilia M Lindgren; Michael V Holmes
Journal:  Sci Transl Med       Date:  2020-06-24       Impact factor: 17.956

Review 6.  Decreased Bone Mineral Density Is an Independent Predictor for the Development of Atherosclerosis: A Systematic Review and Meta-Analysis.

Authors:  Chenyi Ye; Mingyuan Xu; Shengdong Wang; Shuai Jiang; Xi Chen; Xiaoyu Zhou; Rongxin He
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

7.  Relationship between osteopenic syndrome and severity of coronary artery disease detected with coronary angiography and Gensini score in men.

Authors:  Bircan Alan; Veysi Akpolat; Adem Aktan; Sait Alan
Journal:  Clin Interv Aging       Date:  2016-03-24       Impact factor: 4.458

8.  Association of Severity of Coronary Lesions with Bone Mineral Density in Postmenopausal Women.

Authors:  Rui Xu; Xin-Chun Cheng; Yuan Zhang; Hong-Mei Lai; Hong-Ni Yang
Journal:  Arq Bras Cardiol       Date:  2018-03       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.